» Articles » PMID: 1998761

Comparison Between Perindopril and Nifedipine in Hypertensive and Normotensive Diabetic Patients with Microalbuminuria. Melbourne Diabetic Nephropathy Study Group

Overview
Journal BMJ
Specialty General Medicine
Date 1991 Jan 26
PMID 1998761
Citations 41
Affiliations
Soon will be listed here.
Abstract

Objective: To compare the efficacy of angiotensin converting enzyme inhibition with calcium antagonism in diabetic patients with microalbuminuria.

Design: Randomised study of diabetic patients with microalbuminuria treated with perindopril or nifedipine for 12 months and monitored for one or three months after stopping treatment depending on whether they were hypertensive or normotensive. Patients were randomised separately according to whether they were hypertensive or normotensive.

Setting: Diabetic clinics in three university teaching hospitals.

Patients: 50 diabetic patients with persistent microalbuminuria. In all, 43 completed the study: 30 were normotensive and 13 hypertensive; 19 had type I diabetes and 24 had type II diabetes.

Interventions: For 12 months 20 patients were given perindopril 2-8 mg daily and 23 were given nifedipine 20-80 mg daily.

Main Outcome Measures: Albumin excretion rate, blood pressure, and glomerular filtration rate.

Results: Both perindopril and nifedipine significantly reduced mean blood pressure. During treatment there was no significant difference between those treated with perindopril and those treated with nifedipine with respect to albuminuria or mean blood pressure. Stopping treatment with both drugs was associated with a sustained increase in albuminuria and mean blood pressure. There was a significant correlation between mean blood pressure and albuminuria and also between the reduction in mean blood pressure and the decrease in albuminuria during treatment with both drugs. In hypertensive patients both drugs caused significant decreases in mean blood pressure and albuminuria. In normotensive patients there was no significant reduction in albuminuria with either regimen.

Conclusions: In diabetic patients with microalbuminuria blood pressure seems to be an important determinant of urinary albumin excretion. Perindopril and nifedipine have similar effects on urinary albumin excretion, both preventing increases in albuminuria in normotensive patients and decreasing albuminuria in hypertensive patients.

Citing Articles

The effect of renin-angiotensin-aldosterone system inhibitors on continuous and binary kidney outcomes in subgroups of patients with diabetes: a meta-analysis of randomized clinical trials.

Alsalemi N, Sadowski C, Elftouh N, Louis M, Kilpatrick K, Houle S BMC Nephrol. 2022; 23(1):161.

PMID: 35484505 PMC: 9052620. DOI: 10.1186/s12882-022-02763-1.


Short- and long-term treatment with angiotensin-converting enzyme inhibitors or calcium channel blockers for the prevention of diabetic nephropathy progression: A meta-analysis.

Liang J, Lan J, Tang Q, Ling W, Li M Exp Ther Med. 2020; 21(1):14.

PMID: 33235623 PMC: 7678606. DOI: 10.3892/etm.2020.9446.


First-line renin-angiotensin system inhibitors vs. other first-line antihypertensive drug classes in hypertensive patients with type 2 diabetes mellitus.

Wang G, Chen Y, Li L, Tang W, Wright J J Hum Hypertens. 2018; 32(7):494-506.

PMID: 29713053 DOI: 10.1038/s41371-018-0066-x.


Recent Advances in Pharmacological Management of Hypertension in Diabetic Patients with Nephropathy : Effects of Antihypertensive Drugs on Kidney Function and Insulin Sensitivity.

Baba T, Ishizaki T Drugs. 2017; 43(4):464-489.

PMID: 28421556 DOI: 10.2165/00003495-199243040-00004.


Comparative Efficacy and Safety of Antihypertensive Agents for Adult Diabetic Patients with Microalbuminuric Kidney Disease: A Network Meta-Analysis.

Huang R, Feng Y, Wang Y, Qin X, Melgiri N, Sun Y PLoS One. 2017; 12(1):e0168582.

PMID: 28045910 PMC: 5207630. DOI: 10.1371/journal.pone.0168582.


References
1.
Baba T, Murabayashi S, Takebe K . Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial. Diabetologia. 1989; 32(1):40-4. DOI: 10.1007/BF00265402. View

2.
Cooper M, Allen T, OBrien R, Macmillan P, Clarke B, Jerums G . Effects of genetic hypertension on diabetic nephropathy in the rat--functional and structural characteristics. J Hypertens. 1988; 6(12):1009-16. DOI: 10.1097/00004872-198812000-00009. View

3.
Cooper M, Allen T, Macmillan P, Clarke B, Jerums G, Doyle A . Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rat. Diabetologia. 1989; 32(5):326-8. DOI: 10.1007/BF00265552. View

4.
Bach L, Sharpe K . Sample size for clinical and biological research. Aust N Z J Med. 1989; 19(1):64-8. DOI: 10.1111/j.1445-5994.1989.tb01681.x. View

5.
Anderson S, Rennke H, Garcia D, Brenner B . Short and long term effects of antihypertensive therapy in the diabetic rat. Kidney Int. 1989; 36(4):526-36. DOI: 10.1038/ki.1989.227. View